These slides are the property of the presenter. Do not duplicate without express written consent.
|
|
- Gervais Hodges
- 5 years ago
- Views:
Transcription
1 Cancer Survivorship Protecting Against Vaccine Preventable Diseases Heidi Loynes BSN, RN Immunization Nurse Educator Michigan Department of health and Human Services (MDHHS)
2 Are Vaccine-Preventable Diseases Still Out There? Images courtesy of CDC. 2
3 Despite the U.S. immunization program s success, according to CDC officials, 189 people in the U.S. have been reported to have measles this year in 5 outbreaks, as of May 1, 2015 April 1,
4 More Headlines Nonmedical Vaccine Exemptions and Pertussis in California, 2010, Atwell et al, Pediatrics 2013;132:
5 Importance of Vaccinating the Immunocompromised The number of patients with immunosuppression is increasing People with compromised immune systems (cancer, HIV infection, Crohn s, etc.) are vulnerable to illness Vaccination rates tend to be lower in patients with compromised immune systems Partly because the provider may be concerned about safety and effectiveness Resource: Clinical Practice Guideline for the Vaccination of the Immunocompromised Host, Clinical Infectious Diseases, Infectious Disease Society of America (IDSA) at: Vaccination of immunocompromised patients, Clinical Microbiology and Infection Volume 18, Supplement 5, October
6 Why Vaccinate Cancer Survivors? Vaccination are important Survivors are at elevated risk for infection because of cancer treatment Adults with cancer are recommended to receive appropriate vaccinations as part of standard practice In 2009, only 57.8% of adult cancer survivors reported receiving an influenza vaccination Only 48.3% reported receiving an pneumococcal vaccination People who are compromised are at increased risk for flu and pneumococcal disease National guidelines recommend certain vaccines (e.g., inactivated influenza vaccine and pneumococcal vaccines) specifically for cancer survivors NCCN guidelines recommend that all cancer survivors be considered for appropriate vaccinations Medscape, New Cancer Survivorship Guidelines Issued by NCCN ; Crystal S. Denlinger, MD,
7 Challenges to Vaccination of Cancer Survivors Vaccines as a strategy to prevent infection in cancer and transplant survivors can have challenges May not trigger protective immune responses Especially in actively immunocompromised individuals or survivors with residual immune deficits Some vaccines (Zoster, MMR) are contraindicated in actively immunocompromised individuals Ideally providers should administer all indicated vaccines to patients before initiation of cancer treatment Should recommend and encourage the administration of all inactivated vaccines Medscape, New Cancer Survivorship Guidelines Issued by NCCN ; Crystal S. Denlinger, MD,
8 Give a Strong Recommendation Studies consistently show that provider recommendation is the strongest predictor of vaccination Adults who are initially reluctant, are likely to receive a vaccination when the health care provider s opinion of the vaccine is positive Atkinson, William, et al. Epidemiology and Prevention of Vaccine Preventable Diseases, 12th Ed MMWR 2010;Vol 59(08);1-62
9 Vaccinating Cancer Survivors Vaccines are especially critical for people with health conditions such as a weakened immune system
10 Preparing to Vaccinate Determination of altered immunocompetence is important to the vaccine provider Why? Incidence or severity of some vaccine-preventable diseases is higher in persons with altered immunocompetence Vaccines might be less effective during the period of altered immunocompetence Vaccinating a Cancer Survivor involves: Screening (for precautions and contraindications) Physician, PA, NP in clinical decision Risk versus benefit Determining which vaccines to administer (assessment)
11 Recommended Schedule for Adults 2015 Recommended vaccinations indicated for adults based on medical and other indications 11
12 Recommending Vaccines to Cancer Survivors Specialist caring for the immunocompromised share responsibility with the primary care provider Ensure appropriate vaccination to the immunocompromised Recommend appropriate vaccinations of household contacts Vaccines considered safe for cancer, transplant survivors & close contacts: Pneumococcal vaccine (both types) Pneumococcal Conjugate (PCV13) Pneumococcal Polysaccharide (PPSV23) Inactivated Influenza Vaccine (IIV3, IIV4) Tetanus, diphtheria, pertussis (Tdap, Td, DTaP) Hepatitis A and Hepatitis B Inactivated poliovirus (IPV) Haemophilus Influenza type b (Hib) Meningococcal Conjugate (MCV4) Human papillomavirus (HPV) Resource: Clinical Practice Guideline for the Vaccination of the Immunocompromised Host, Clinical Infectious Diseases, Infectious Disease Society of America (IDSA) at:
13 Vaccines Contraindicated in Actively Immunocompromised Survivors Live attenuated vaccines Influenza---Live, Attenuated Influenza Vaccine (LAIV) Measles, Mumps, Rubella (MMR) Varicella Zoster Oral Polio Rotavirus Oral Typhoid Yellow Fever
14 Pneumococcal Vaccines Most common pneumococcal disease is pneumococcal pneumonia which is a frequent complication of influenza Accounts for an estimated 400,000 hospitalizations per year Case fatality rate 5-7%, higher in elderly There are 2 Pneumococcal vaccines PCV13 (Pneumococcal Conjugate Vaccine) Brand name: Prevnar13 Given IM to ages 2 months and older PPSV23 (Pneumococcal Polysaccharide Vaccine) Brand name: Pneumovax Given IM to ages 2 years and older If both vaccines are recommended: Do not give these 2 vaccines at the same visit Administer PCV13 first (preferred) then PPSV23 Intervals between PCV13 & PPSV23 based on age and risk 20
15 PCV13 and PPSV23 PCV13 (Prevnar13 ) For Persons 6 Years and Older For persons with a high risk indication and no previous dose of PCV13: Administer 1 dose to persons aged 6-64 years with: CSF leaks, cochlear implants Immunosuppression caused by disease or medications, HIV, functional or anatomic asplenia, sickle cell, general malignancy Routinely administer 1 dose to all persons aged 65 years and older with no previous dose of PCV13 PPSV23 (Pneumovax ) For persons with a high risk indication: Administer 1 dose to persons aged years who Smoke cigarettes or have asthma Administer 1 dose to persons aged 2-64 years with: Chronic pulmonary, kidney or heart disease, diabetes mellitus, alcoholism, CSF leaks, or cochlear implants Administer 2 doses to persons aged 2-64 years with: Immunosuppression caused by disease or medications, HIV, functional (sickle cell) or anatomic asplenia, malignancy Minimum interval between 2 doses is 5 years Routinely administer 1 dose to all persons age 65 years or older Final PPSV23 dose regardless of risk factor
16 Administering PCV13 and PPSV23 Age Group 19 years 65 years Underlying Conditions High-risk immunocompetent (CSF leak, cochlear implant) Functional or anatomic asplenia Immunocompromised Immunocompetent not in a risk group listed under 19 years Recommended Intervals PCV13 to PPSV weeks PPSV23 to PCV13 12 months 12 months 12 months 1 Recommended: PCV13 be given prior to PPSV23 (red box) 24
17 Burden of Influenza Disease Difficult to predict severity or timing 5%-20% of U.S. population infected Range of 3,000-49,000 (average 23,600) influenzarelated deaths annually in the U.S. Rates of serious illness & death greatest in: Persons aged 65 years and older Children less than 2 years of age Persons (any age) with medical conditions that put them at high risk for complications from influenza Having or surviving cancer does not put you at an increased risk for getting the flu It does put you at an increased risk of complications from the flu virus Such as: pneumonia, hospitalization, and even death
18 Flu Coverage in High Risk Adults High-risk adults aged years: U.S. 39.3% MI 43.4% (+12.8% from ) High-risk adults aged years: U.S. 47.6% MI 46.9% (+6.1% from )
19 Immunization Recommendations: Everyone! Every Year! All persons 6 months of age and older should be given flu vaccine every year Continue to ensure that persons at higher risk for influenza-related complications are vaccinated If you are a cancer survivor, you are still at higher risk for flu-related complications Vaccinate close contacts of those at high risk to provide another layer of protection including: Healthcare Personnel (HCP) Parents & contacts of infants less than 6 months of age
20 Two Types of Inactivated Influenza Vaccine (IIV) Inactivated Influenza Vaccine, Trivalent Inactivated Influenza Vaccine, Quadrivalent IIV3 (flu shot, IM) IIV4 (flu shot, IM) 3 flu strains: 2 A, 1 B 4 flu strains: 2 A, 2 B Age 6 months/older** Age 6 months/older** For persons who: - Are healthy - Have any underlying medical condition - Are pregnant For persons who: - Are healthy - Have any underlying medical condition - Are pregnant **Age indication varies by vaccine brand Live attenuated influenza vaccine (LAIV4) is contraindicated in the immunocompromised
21 Influenza Vaccines IIV: Inactivated Influenza Vaccine, trivalent (IIV3) or quadivalent (IIV4) LAIV4: Live, Attenuated, Influenza Vaccine, quadrivalent cciiv3: Cell Culture-based Inactivated Influenza Vaccine, trivalent RIV3: Recombinant Influenza Vaccine, trivalent Vaccine Type Brand Age Indication Manufacturer TRIVALENT (IIV3) IIV3 *Fluzone 6 months and older sanofi pasteur IIV3 Fluvirin 4 years & older Novartis IIV3/Jet Injector¹ Afluria 9 years & older biocsl IIV3 High Dose Fluzone High Dose 65 years & older sanofi pasteur cciiv3 Flucelvax 18 years & older Novartis RIV3 Flublok 18 years & older Protein Sciences QUADRIVALENT (IIV4 & LAIV4) IIV4 *Fluzone Quadrivalent 6 months and older sanofi pasteur IIV4 *Fluarix Quadrivalent 3 years & older GlaxoSmithKline IIV4 *FluLaval Quadrivalent 3 years & older GlaxoSmithKline IIV4 ID Fluzone Intradermal 18 through 64 years sanofi pasteur LAIV4 Contraindicated *FluMist Quadrivalent Healthy, non-pregnant persons 2 through 49 years MedImmune *Available for VFC Providers ¹Afluria was approved by the Food and Drug Administration for intramuscular administration with the PharmaJet Stratis needle-free jet injector system for persons 18 through 64 years of age
22 Hematopoietic Stem Cell Transplant (HSCT) Recipients At increased risk for certain vaccine-preventable diseases Including diseases caused by encapsulated bacteria (i.e., pneumococcal, meningococcal and Hib infections) HCT recipients should be revaccinated Regardless of the source of the transplanted stem cells Most inactivated vaccines should be initiated 6 months after the HCT Follow minimum intervals between doses References: Tomblyn M, Chiller T, Einsele H, et al. Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective, Biol Blood Marrow Transplant 15: ;2009 Rubin, LG, Levin MJ, Ljungman P., et. Al IDSA Clinical Practice Guidelines for Vaccination of the Immunocompromist Hot. Clin. Infect. Dis. 2014; 58: e
23 Vaccination of HSCT Recipients Inactivated influenza vaccine (IIV) Administer at least 6 months after HSCT and annually thereafter May administer as early as 4 months post HSCT if community outbreak as defined by the local health department However, 2 nd dose should be considered if flu vaccine given before 6 months post HSCT (at least 4 weeks later) Tetanus, diphtheria acellular pertussis vaccines Start series 6 months after HSCT DTaP is preferred (3 doses) Alternatively, if only Tdap available (give one Tdap followed by 2 doses of DT or Td for a total of 3 doses) Hib vaccine Administer 3 doses 6-12 months post HSCT; at least 1 month should separate the doses
24 Protecting Our At-Risk Population Goal is to ensure we vaccinate against vaccine-preventable diseases To help provide protection for our vulnerable (at-risk ) population We do this by: Recommending and administering vaccines for our cancer patients and cancer survivors Ensuring that household contacts are vaccinated Why is vaccinating household contacts and the general population important? Because Herd immunity (cocooning) makes a difference Implies that disease risk will be reduced for susceptible persons by the presence & proximity of immune individuals ( indirect protection )
25 Continue the Survivorship Vaccinate to Protect our At-Risk
26 Thank You Heidi Loynes BSN, RN Immunization Nurse Educator Michigan Department of health and Human Services (MDHHS)
27 Resources 1. Clinical Practice Guideline for the Vaccination of the Immunocompromised Host, Clinical Infectious Diseases, Infectious Diseases Society of America (IDSA) at: 2. General Recommendations on Immunization, Recommendations of the Advisory Committee on Immunization Practices (ACIP), MMWR; Vol.60p; No.2; January 28, What Cancer Patients, Survivors, and Caregivers Should Know About the Flu at: 4. Influenza vaccination for immunocompromised patients: systematic review and meta-analysis by etiology at: 5. Vaccination of immunocompromised patients Clinical Microbiology and Infection Volume 18, Supplement 5, October 2012 at 6. Clinical Practice Guideline for the Vaccination of the Immunocompromised Host, Clinical Infectious Diseases, Infectious Disease Society of America (IDSA) at: 7. Weakened Immune System and Adult Vaccination at: 8. Vaccination of Persons with Primary and Secondary Immune Deficiencies at: 9. Vaccination of Hematopoietic Stem Cell Transplant (HSCT) Recipients at:
HIT ME WITH YOUR BEST SHOT: UPDATE ON IMMUNIZATIONS. Karen Hoang, PharmD Clinical Pharmacy Specialist, MTM Services UPMC Health Plan
HIT ME WITH YOUR BEST SHOT: UPDATE ON IMMUNIZATIONS Karen Hoang, PharmD Clinical Pharmacy Specialist, MTM Services UPMC Health Plan DISCLOSURES No financial or other conflicts to disclose LEARNING OBJECTIVES
More informationImmunization Update 2013 Across the Lifespan
Immunization Update 2013 Across the Lifespan Andrew Kroger M.D., M.P.H. Medical Officer, Centers for Disease Control and Prevention New York State Association of County Health Officials (NYSACHO) New York
More informationPREVENTIVE IMMUNIZATIONS. PREVENTIVE IMMUNIZATIONS These codes do not have a diagnosis code requirement for preventive benefits to apply.
An immunization that does not fall under one of the exclusions in the Certificate of Coverage is considered covered after the following conditions are satisfied: (1) FDA approval; (2) explicit ACIP recommendation
More informationPREVENTIVE IMMUNIZATIONS. PREVENTIVE IMMUNIZATIONS These codes do not have a diagnosis code requirement for preventive benefits to apply.
An immunization that does not fall under one of the exclusions in the Certificate of Coverage is considered covered after the following conditions are satisfied: (1) FDA approval; (2) explicit ACIP recommendation
More informationNeedle Facts: Immunization Update Mirada Wilhelm, PharmD Clinical Associate Professor SIUE School of Pharmacy
Needle Facts: Immunization Update 2015 Mirada Wilhelm, PharmD Clinical Associate Professor SIUE School of Pharmacy Objectives Pharmacists At the conclusion of this program, the pharmacist will be able
More informationKenneth McCall, BSPharm, PharmD Associate Professor UNE
Kenneth McCall, BSPharm, PharmD Associate Professor UNE Objectives Discuss the gap between current rates and Healthy People 2020 goals for vaccinations. Categorize each of the CDC recommended flu vaccines
More informationSummary of Recommendations for Adult Immunization (Age 19 years and older) (Page 2 of 5)
Summary of Recommendations for Adult Immunization (Age 19 years and older) (Page 1 of 5) Influenza Inactivated Influenza (IIV*) or ID (intradermally) *includes recombinant influenza (RIV) Live attenuated
More informationUpdate on Adult Immunization
Update on Adult Immunization Paul J. Carson, MD, FACP Sanford Health, Infectious Disease NDSU Master of Public Health Program UND School of Medicine and Health Sciences When meditating over a disease,
More informationWhat DO the childhood immunization footnotes reveal? Questions and answers
What DO the childhood immunization footnotes reveal? Questions and answers Stanley E. Grogg, DO, FACOP, FAAP he Advisory Committee on Immunization Practices (ACIP) recommends the childhood vaccination
More informationNOTE: The above recommendations must be read along with the footnotes of this schedule.
Figure 1. Recommended immunization schedule for persons aged 0 through 18 years 2013. (FOR THOSE WHO FALL BEHIND OR START LATE, SEE THE CATCH-UP SCHEDULE [FIGURE 2]). These recommendations must be read
More information3 rd dose. 3 rd or 4 th dose, see footnote 5. see footnote 13. for certain high-risk groups
Figure 1. Recommended immunization schedule for persons aged 0 through 18 years 2013. (FOR THOSE WHO FALL BEHIND OR START LATE, SEE THE CATCH-UP SCHEDULE [FIGURE 2]). These recommendations must be read
More informationAdult Immunization Update 2015
Adult Immunization Update 2015 Objectives Upon completion of this session, the pharmacist should be able to: Compare and contrast previous versions of the ACIP immunization schedules with the most recent
More informationAdvisory Committee on Immunization Practices VACCINE ACRONYMS
Vaccine Acronyms Page 1 of 5 Advisy Committee on Immunization Practices VACCINE ACRONYMS Vaccines Included in the Immunization Schedules f Children, Adolescents, and Adults Following is a table of standardized
More informationTRICARE Retail Vaccination Program Vaccine List - September 2018*
Diphtheria, tetanus and pertussis Diphtheria and tetanus toxoids adsorbed acellular pertussis adsorbed DT DTaP Diphtheria and tetanus toxoids adsorbed Daptacel, Infanrix Tetanus and diphtheria toxoids
More informationImmunization Guidelines for the Use of State Supplied Vaccine April 18, 2013
DTaP / DT DTaP/IPV/Hep B Combination (Pediarix ) Children from 6 weeks of age up to the 7 th birthday Children from 2 months of age up to the 7th birthday: Indicated for the primary doses of DTaP, IPV,
More informationImmunization Update. William Atkinson, MD, MPH. Immunization Action Coalition
Immunization Update William Atkinson, MD, MPH Immunization Action Coalition Coordinated School Health Conference Lake Ozark, Missouri December 3, 2016 1 Disclosures William Atkinson has no financial relationships
More informationImmunization Update: New CDC Recommendations. Blaise L. Congeni M.D. 2012
Immunization Update: New CDC Recommendations Blaise L. Congeni M.D. 2012 Polysaccharide Vaccines Vaccine Hib capsule polysaccharide PRP (polyribose ribitol phosphate) Not protective in infants
More informationUPDATE ON IMMUNIZATION GUIDELINES AND PRACTICES
DISCLOSURES UPDATE ON IMMUNIZATION GUIDELINES AND PRACTICES Nothing to disclose Kylie Mueller, Pharm.D., BCPS Clinical Specialist, Infectious Diseases Spartanburg Regional Medical Center LEARNING OBJECTIVES
More informationSummary of Recommendations for Adult Immunization (Age 19 years and older) PAGE 1 OF 5
Summary of Recommendations for Adult Immunization (Age 19 years and older) PAGE 1 OF 5 Influenza Inactivated Influenza vaccine (IIV*) or ID (intradermally) * includes recombinant influenza vaccine (RIV3)
More informationACIP Meeting Update, New Recommendations and Pending Influenza Season
ACIP Meeting Update, New Recommendations and Pending Influenza Season February 17 th 2011 www.immunizetexas.com ACIP Upcoming Agenda and New Recommendations ACIP (February 23-24 th 2011) Topics for meeting
More informationCoverage of Vaccines Medicaid and Child Health Plus Members
Coverage of Vaccines Medicaid and Child Health Plus Members For children between the ages 0-18, routine recommended vaccinations are covered through Vaccines for Children program [VFC]. Fidelis Care will
More informationCigna Drug and Biologic Coverage Policy
Cigna Drug and Biologic Coverage Policy Subject Routine Immunizations Table of Contents Coverage Policy... 1 General Background... 2 Coding/Billing Information... 3 References... 7 Effective Date... 4/15/2018
More informationRECOMMENDED IMMUNIZATIONS
Recommended Immunization Schedule for Persons Aged 0 Through 6 Years United States 2010 1 2 4 6 12 15 18 19 23 2 3 4 6 Vaccine Age Birth month months months months months months months months years years
More informationImmunization Guidelines For the Use of State Supplied Vaccine July 1, 2011
DTaP / DT DTaP/IPV/Hep B Combination (Pediarix ) Children from 6 weeks of age up to the 7 th birthday Children from 2 months of age up to the 7th birthday: Indicated for the primary doses of DTaP, IPV,
More informationImmunization Guidelines for the Use of State Supplied Vaccine May 17, 2015
DTaP / DT DTaP/IPV/Hep B Combination (Pediarix ) Children from 6 weeks of age up to the 7 th birthday Children from 2 months of age up to the 7th birthday: Indicated for the primary doses of DTaP, IPV,
More informationVaccine Preventable Diseases Among Adults
Vaccine Preventable Diseases Among Adults Stephanie Borchardt, MPH, PhD Wisconsin Immunization Program Division of Public Health Wisconsin Department of Health Services November 17, 2016 At a Glance Burden
More informationVaccinations for Adults
Case: Vaccinations for Adults Lisa Winston, MD University of California, San Francisco San Francisco General Hospital A 30-year old healthy woman comes for a routine visit. She is recently married and
More informationBenefit Interpretation
Benefit Interpretation Subject: Part B vs. Part D Vaccines Issue Number: BI-039 Applies to: Medicare Advantage Effective Date: May 1, 2017 Attachments: Part B Vaccines Diagnosis Code Limits Table of Contents
More informationWhat are the new active vaccine recommendations in the Canadian Immunization Guide?
154 CCDR 17 April 2014 Volume 40-8 https://doi.org/10.14745/ccdr.v40i08a03 1 What are the new active vaccine recommendations in the Canadian Immunization Guide? Warshawsky B 1 and Gemmill I 2 on behalf
More informationAdult Immunization, Patient-Centered Medical Care, and the Primary Physician
Adult Immunization, Patient-Centered Medical Care, and the Primary Physician John H. O Neill, Jr., D.O., FACP Bayview Internal Medicine, Inc., Middletown, Delaware Chair, Immunization Technical Advisory
More informationNOTE: The above recommendations must be read along with the footnotes of this schedule.
Figure 1. Recommended immunization schedule for persons aged 0 through 18 years United States, 2014. (FOR THOSE WHO FALL BEHIND OR START LATE, SEE THE CATCH-UP SCHEDULE [FIGURE 2]). These recommendations
More informationAdvisory Committee on Immunization Practices VACCINE ACRONYMS
May 1, 2015 Vaccine Acronyms Page 1 of 5 Advisy Committee on Immunization Practices VACCINE ACRONYMS Vaccines Included in the Immunization Schedules f Children, Adolescents, and Adults Following is a table
More informationNew Vaccine Schedules. Disclosure. Overview. Immunization Recommendations in Primary Care. Objectives Pharmacists. Objectives Pharmacy Technicians
Disclosure Immunization Recommendations in Primary Care I have nothing to disclose. Betsy Blake, PharmD, BCPS October 2017 Objectives Pharmacists Learning Objectives: At the completion of this activity,
More informationNew Jersey Department of Health Vaccine Preventable Disease Program Childhood and Adolescent Recommended Vaccines
New Jersey Department of Health Vaccine Preventable Disease Program Childhood and Adolescent Recommended Vaccines Antigens Vaccine Approved Age Daptacel Diphtheria, Tetanus, and acellular Pertussis (DTaP)
More informationImmunization Update: What s New in 2013? Thursday, August 15, :30 a.m. 12:30 p.m.
Immunization Update: What s New in 2013? Thursday, August 15, 2013 11:30 a.m. 12:30 p.m. Presented by: Lynn Trefren, RN Nurse Manager, Tri-County Health Department Deb Zambrano, PHNC Vaccines for Children
More informationDiclosures. Objectives 12/29/17
Kristy Brittain, PharmD, BCPS, CDE Associate Professor, MUSC College of Pharmacy Clinical Pharmacy Specialist, Medical University of SC Diclosures Kristy Brittain has no conflict of interest to report.
More informationVaccine Label Examples
Vaccine Label Examples With the large amount of vaccine carried in most clinics, staff can easily become confused about vaccines within the storage unit. Labeling the area where vaccines are stored can
More informationGuidelines for Vaccinating Pregnant Women
Guidelines for Vaccinating Pregnant Women April 2013 Guidelines for Vaccinating Pregnant Women Abstracted from recommendations of the Advisory Committee on Immunization Practices (ACIP) April 2013 Risk
More informationImmunization Update Tamara Sheffield, MD, MPA, MPH
Immunization Update 2015 Tamara Sheffield, MD, MPA, MPH Disclosure I do not have any relevant financial relationships with any commercial interests I am a Medical Director employed by Intermountain Healthcare
More informationVaccines Indicated for Infants, Children, and Adolescents Based on Medical and Other Indications
Vaccines Indicated for Infants, Children, and Adolescents Based on Medical and Other Indications Vaccine Prematurity 1 Altered Immunocompetence 2 (excluding human immunodefi ciency virus [HIV] infection)
More informationVaccines in Immunocompromised hosts
Vaccines in Immunocompromised hosts Carlos del Rio, MD Emory Center for AIDS Research October 2013 Immunocompromised hosts Number has increased rapidly in the past decades Broad term that encompasses different
More informationImmunization Recommendations for College Students
May 2017 ACHA Guidelines Immunization Recommendations for College Students Immunizations offer safe and effective protection from vaccine-preventable diseases and outbreaks. The United States is experiencing
More information07/20/17, 05/17/18 CATEGORY: Vaccines/Biologics. Proprietary Information of Excellus Health Plan, Inc.
MEDICAL POLICY SUBJECT: IMMUNIZATIONS PAGE: 1 OF: 9 If a product excludes coverage for a service, it is not covered, and medical policy criteria do not apply. If a commercial product (including an Essential
More informationVaccine Label Examples
Vaccine Label Examples With the large amount of vaccine carried in most clinics, staff can easily become confused about vaccines within the storage unit. Labeling the area where vaccines are stored can
More informationNeedle Facts: Immunization Update 2017
Needle Facts: Immunization Update 2017 Miranda Wilhelm, Pharm.D. Clinical Associate Professor Southern Illinois University Edwardsville (SIUE) School of Pharmacy Disclosure and Conflict of Interest Miranda
More informationGuidelines for Vaccinating Pregnant Women
Guidelines for Vaccinating Pregnant Women March 2012 Guidelines for Vaccinating Pregnant Women Abstracted from recommendations of the Advisory Committee on Immunization Practices (ACIP) MARCH 2012 Risk
More informationHealthy People 2020 objectives were released in 2010, with a 10-year horizon to achieve the goals by 2020.
Appendix 1: Healthy People 2020 Immunization-related Objectives Healthy People provides science-based, 10-year national objectives for improving the health of all Americans. For three decades, Healthy
More informationVaccines, Not Just for Babies
Vaccines, Not Just for Babies Meg Fisher, MD Medical Director Disclosures I have no relevant financial relationships with the manufacturers of any commercial products or commercial services discussed in
More informationImmunization Update 2015
Immunization Update 2015 JoEllen Wolicki BSN, RN Immunization Services Division National Center for Immunization and Respiratory Diseases Tennessee Annual Spring Immunization Review April 2015 National
More informationImmunization Update 2016 Clinical Learning Day. Tamara Sheffield, MD, MPA, MPH
Immunization Update 2016 Clinical Learning Day Tamara Sheffield, MD, MPA, MPH Disclosure I do not have any relevant financial relationships with any commercial interests I am a Medical Director employed
More informationNothing to disclose. Vaccinations for Adults and Adolescents: An Update. Key Resource
Vaccinations for Adults and Adolescents: An Update Nothing to disclose. Lisa G. Winston, MD Professor of Medicine, University of California, San Francisco Vice Chief, Inpatient Medical Services and Hospital
More information2017 Immunization Update for Pharmacy Professionals
2017 Immunization Update for Pharmacy Professionals North Suburban Pharmacists of Chicagoland CPE Program May 3, 2017 Lauren B. Angelo, PharmD, MBA Associate Professor Rosalind Franklin University of Medicine
More information10/16/2018. Be Discuss. Describe. Discuss. Discuss 2018 ADULT IMMUNIZATION SCHEDULE INFLUENZA ADULT IMMUNIZATION UPDATE TRAINING OBJECTIVES FLUMIST
ADULT IMMUNIZATION UPDATE NORTH DAKOTA ACADEMY OF FAMILY PHYSICIANS NOVEMBER 10, 2018 Be Discuss Upon completion of the adult immunization training, participants will be able to: Discuss the general adult
More informationRecommended Immunization Schedules for Persons Aged 0 Through 18 Years UNITED STATES, 2016
Recommended Immunization Schedules for Persons Aged 0 Through 18 Years UNITED STATES, 2016 This schedule includes recommendations in effect as of January 1, 2016. Any dose not administered at the recommended
More informationVaccines are Not Just for Kids
Vaccines are Not Just for Kids Stephanie Borchardt, MPH, PhD Wisconsin Immunization Program Division of Public Health Wisconsin Department of Health Services November 15, 2018 At a Glance Burden of vaccine
More informationAll Kindergarteners and 4-6 year old transfer students. 4 doses DTP or DTaP 1 dose must be at or after 4 years of age. None
Parents Vaccines Required for School Entry in Michigan Whenever children are brought into group settings, there is a chance for diseases to spread. Children must follow state vaccine laws in order to attend
More informationNeedle Facts: Immunization Update 2016
Needle Facts: Immunization Update 2016 Miranda Wilhelm, Pharm.D. Clinical Associate Professor Southern Illinois University Edwardsville School of Pharmacy Disclosure / Conflict of Interest Miranda Wilhelm
More informationAppendix An Assessment Tool to Determine the Validity of Vaccine Doses
Appendix 4.4 - An Assessment Tool to Determine the Validity of Vaccine Doses Note: Refer to the Canadian Immunization Guide and New Brunswick (NB) immunization program directives for recommendations for
More informationImmunizations to Reduce Disease H. Keipp Talbot, M.D., M.P.H.
Immunizations to Reduce Disease H. Keipp Talbot, M.D., M.P.H. Vanderbilt University School of Medicine 1 DISCLOSURES Financial Relationships with Relevant Commercial Interests Receive research funding
More informationRevisions to Communicable Disease Control Manual: Chapter 2 Immunization Program
January 5, 2010 ATTN: Medical Health Officers and Branch Offices Public Health Nursing Administrators and Assistant Administrators Holders of Communicable Disease Control Manuals Re: Revisions to Communicable
More informationSlide 1. Slide 2 Disclosure. Slide 3 Learning Objectives
Slide 1 2016 Immunization Update for Pharmacists Miranda Wilhelm, Pharm.D. Clinical Associate Professor Southern Illinois University Edwardsville School of Pharmacy Slide 2 Disclosure Miranda Wilhelm reports:
More information2/16/2015 IMMUNIZATION UPDATE Kelly Ridgway, RPh February 21, Today s Overview NEW RECOMMENDATIONS
IMMUNIZATION UPDATE 2015 Kelly Ridgway, RPh February 21, 2015 Today s Overview 1 2 3 4 5 6 Pneumococcal Vaccine Recommendations Meningococcal Vaccine Recommendations HPV Vaccine Recommendations Patient
More informationAdult Vaccine Products
Adult Vaccine Products Reference Guide As always, FFF goes Beyond Distribution in its commitment to lead with integrity and a patient-centered focus. We are constantly seeking innovative solutions to reinforce
More informationVaccines and Adults: Our Collective Challenge Webinar
Vaccines and Adults: Our Collective Challenge Webinar Questions 1. What documentation would a pediatrician need to immunize adult parents to avoid some risk since they are non-patients of the practice
More informationImmunization Update Clark Kebodeaux, Pharm.D., BCACP
Immunization Update 2015 Clark Kebodeaux, Pharm.D., BCACP Objectives Describe the Advisory Committee on Immunization Practices (ACIP) recommendations and updates for 2014/2015 that guide current immunization
More informationPolicy and Procedure Manual
Policy and Procedure Manual Medication Management MM.3-6 SUBJECT/TITLE: PURPOSE: DEFINITION: ADULT, INPATIENT PNEUMOCOCCAL AND SEASONAL INFLUENZA VACCINATION To ensure that adult inpatients who are candidates
More informationSeries of 2 doses, 6-12 months apart. One dose is 720 Elu/0.5ml (GSK) or 25 u/0.5 ml (Merck)
UTAH PREVENTIVE CARE RECOMMENDATIONS Adult - Ages 19 and Above IMMUNIZATIONS CONTENTS: General Instructions Hepatitis A Hepatitis B Human Papilloma Virus Influenza Meningococcal A, C, Y, W (MCV4) Meningococcal
More informationInfluenza Update. Lisa Grohskopf, MD, MPH Influenza Division, CDC. NAICP Call 6 October 2015
Influenza Update Lisa Grohskopf, MD, MPH Influenza Division, CDC NAICP Call 6 October 2015 National Center for Immunization and Respiratory Diseases Influenza Division Overview Surveillance update ACIP
More informationKenneth McCall, BSPharm, PharmD Associate Professor UNE President Maine Pharmacy Association
Kenneth McCall, BSPharm, PharmD Associate Professor UNE President Maine Pharmacy Association Objectives Discuss the gap between current rates and Healthy People 2020 goals for vaccinations. Categorize
More informationTalkin Flu Mid-America Immunization Coalition August 18, William Atkinson, MD, MPH Immunization Action Coalition
Talkin Flu Mid-America Immunization Coalition August 18, 2016 William Atkinson, MD, MPH Immunization Action Coalition Disclosures William Atkinson has worked as a consultant to Merck and as a speaker for
More informationChildhood Immunization Status
emeasure Title emeasure Identifier (Measure Authoring Tool) Childhood Immunization Status 117 emeasure Version number 5.1.000 NQF Number 0038 GUID b2802b7a-3580-4be8-9458- 921aea62b78c Measurement Period
More informationCPT 2016 Code Changes
CPT 2016 Code Changes Code Changes - Medicine New CPT 2016 New Codes Code Description 69209 Removal impacted cerumen using irrigation/lavage, unilateral 90620 Meningococcal recombinant protein and outer
More informationFlu Vaccine Access Via Pharmacy Vaccine Network
Re: Flu Vaccine Access Via Pharmacy Vaccine Network Effective 9/15/2016, IEHP Medi-Cal and Medicare DualChoice Cal MediConnect (IEHP Direct) Members who are over 18 years old may obtain Flu Vaccines through
More informationPOLICIES AND PROCEDURES
Purpose: To establish guidelines for Childhood Preventive Care Screening.To specify and define the Alliance guidelines for periodic health screening and preventive health services for members up to 21
More informationModule 7: Case Discussion and Administration Technique
: Case Discussion and Administration Technique Miranda Wilhelm, Pharm.D. Clinical Associate Professor Department of Pharmacy Practice Southern Illinois University Edwardsville, School of Pharmacy 1 Disclosure
More informationPennsylvania Academy of Family Physicians Foundation & UPMC 43rd Refresher Course in Family Medicine CME Conference March 10 13, 2016
Pennsylvania Academy of Family Physicians Foundation & UPMC 43rd Refresher Course in Family Medicine CME Conference March 10 13, 2016 Disclosures: Immunizations Donald Middleton, MD & Richard Zimmerman,
More informationImmunizations June 5, Brenda Ormesher, MD Infectious Disease Peacehealth Medical Group Springfield, OR
Immunizations June 5, 2015 Brenda Ormesher, MD Infectious Disease Peacehealth Medical Group Springfield, OR Disclosures None Goals Understand basic public health impact of immunization Recognize types
More informationAPEC Guidelines Immunizations
Pregnancy provides an excellent opportunity to enhance a woman s protection against disease and to provide protection to the neonate during the first 3 to 6 months of life. Women of childbearing age should
More informationNothing to disclose. Vaccinations for Adults and Adolescents: An Update. Preventative Vaccines
Vaccinations for Adults and Adolescents: An Update Nothing to disclose. Lisa G. Winston, MD University of California, San Francisco San Francisco General Hospital Preventative Vaccines Diseases/Pathogens
More informationGENERAL IMMUNIZATION GUIDE FOR CHILDCARE PROVIDERS August 2018 **CHILD VACCINES** DIPHTHERIA, TETANUS, PERTUSSIS VACCINES
GENERAL IMMUNIZATION GUIDE FOR CHILDCARE PROVIDERS August 2018 **CHILD VACCINES** DIPHTHERIA, TETANUS, PERTUSSIS VACCINES DTaP: Diphtheria, Tetanus, acellular Pertussis Vaccine Infanrix Licensed in 1997
More informationImmunization Resources for Pharmacists
Immunization Resources for Pharmacists TABLE OF CONTENTS Child / Teen Resources Screening Questionnaire Child/Teen... 3 Vaccine Schedule Age 0-6yrs... 5 Catch-Up Schedule 4mo-18yrs... 6 Vaccine Schedule
More informationGuidelines for immunisation of children following treatment with high dose chemotherapy and Haematopoietic Stem Cell Transplantation (HSCT)
Guidelines for immunisation of children following treatment with high dose chemotherapy and Haematopoietic Stem Cell Transplantation (HSCT) Version 2.0 Approved by Haem / Onc Senior Clinical Management
More informationObjectives. Immunity. Childhood Immunization Risk of Non-Vaccinated Children 12/22/2015
Childhood Immunization Risk of Non-Vaccinated Children Bertha P. Rojas, Pharm.D. PGY-1 Pharmacy Resident South Miami Hospital Objectives Understand the definition of herd immunity Identify vaccine-preventable
More information2013 Adult Immunization Update. David H. Spach, MD Professor of Medicine Division of Infectious Diseases University of Washington, Seattle
2013 Adult Immunization Update David H. Spach, MD Professor of Medicine Division of Infectious Diseases University of Washington, Seattle Adult Immunization Update Pertussis Vaccine Influenza Vaccine Zoster
More informationMandates and More. Julie Morita, M.D. Deputy Commissioner Chicago Department of Public Health. Chicago Department of Public Health
Mandates and More Julie Morita, M.D. Deputy Chicago Department of Public Health Why are vaccines required for school entry? School Vaccine Requirements Small pox vaccine required in Massachusetts 1855
More informationExpanding Practice of Pharmacist-Administered Immunizations for 2013
Expanding Practice of Pharmacist-Administered Immunizations for 2013 Rupal Mansukhani, PharmD Clinical Assistant Professor Rutgers University Piscataway, NJ Faculty Information Presenter: Rupal Mansukhani,
More informationOPTIMIZING VACCINE IMMUNITY IN THE IMMUNOCOMRPOMISED PEDIATRIC PATIENT
OPTIMIZING VACCINE IMMUNITY IN THE IMMUNOCOMRPOMISED PEDIATRIC PATIENT Victoria A. Statler, M.D., M.Sc. Division of Pediatric Infectious Diseases Pediatric Transplant Infectious Diseases University of
More informationAdult Immunizations: Ensuring Family Planning Clients are Protected
Objectives Adult Immunization: Identify the recommended vaccines for adults Identify three functions of the Michigan Care Improvement Registry (MCIR) Discuss vaccine procurement options for adults Barbara
More informationImmunization in Cancer Patients:
Immunization in Cancer Patients: An Often Forgotten or Ignored Responsibility E.J. Bow MD, MSc., D. Bacteriol., FRCPC Infectious Diseases, Haematology/Oncology, Blood and Marrow Transplant Director, Infection
More informationNothing to disclose.
Vaccinations for Adults and Adolescents: An Update Lisa G. Winston, MD Professor of Medicine, University of California, San Francisco Vice Chief, Inpatient Medical Services and Hospital Epidemiologist
More informationKeeping up with immunizations for adults
MEDICAL GRAND ROUNDS CME CREDIT EDUCATIONAL OBJECTIVE: Readers will vaccinate their patients according to guidelines from the US Centers for Disease Control and Prevention CRAIG NIELSEN, MD Associate Professor,
More informationNothing to disclose. Vaccinations for Adults and Adolescents: An Update. Outline vaccines to be covered
Vaccinations for Adults and Adolescents: An Update Nothing to disclose. Lisa G. Winston, MD Professor of Medicine, University of California, San Francisco Vice Chief, Inpatient Medical Services and Hospital
More informationChild Health and Disability Prevention (CHDP) Program Code Conversion
Child Health and Disability Prevention (CHDP) Program Code Conversion Health s All s are effective for dates of service on or after July 1, 2017. (Select s for laboratory-only providers with effective
More informationImmunizations are among the most cost effective and widely used public health interventions.
Focused Issue of This Month Recommended by the Korean Pediatric Society, 2008 Hoan Jong Lee, MD Department of Pediatrics, Seoul National University College of Medicine E mail : hoanlee@snu.ac.kr J Korean
More informationNothing to disclose. Vaccinations for Adults and Adolescents: An Update. Key Resource
Vaccinations for Adults and Adolescents: An Update Nothing to disclose. Lisa G. Winston, MD Professor of Medicine, University of California, San Francisco Vice Chief, Inpatient Medical Services and Hospital
More informationImmunization Update 2013
Immunization Update 2013 Andrew Kroger M.D., M.P.H. Centers for Disease Control and Prevention American Academy of Pediatrics Connecticut Chapter December 3, 2013 National Center for Immunization & Respiratory
More informationGuidelines for the immunisation of children following treatment with Standard-Dose Chemotherapy
Guidelines for the immunisation of children following treatment with Standard-Dose Chemotherapy Version 2.0 Approved by Haem / Onc Senior Clinical Management team Date Approved March 2015 Ratified by:
More informationNothing to disclose.
Vaccinations for Adults and Adolescents: An Update Lisa G. Winston, MD Professor of Medicine, University of California, San Francisco Vice Chief, Inpatient Medical Services and Hospital Epidemiologist
More informationI certify that the information provided on this form is correct and verifiable. Month Day Year
Certificate of Immunization Status (CIS) DOH 48-0 January 05 Please print. See back for instructions on how to fill out this form or get it printed from the Immunization Information System. Child s Last
More informationNote from the National Guideline Clearinghouse (NGC): The guideline recommendations are presented in the form of tables with footnotes (see below).
Brief Summary GUIDELINE TITLE Recommended immunization schedules for persons aged 0 through 18 years: United States, 2009. BIBLIOGRAPHIC SOURCE(S) American Academy of Pediatrics Committee on Infectious
More information